Critical role of inflammatory mast cell in fibrosis: Potential therapeutic effect of IL-37

The IL-1 family of cytokines. Do they have a role in scleroderma fibrosis?

(2018) Carol M. Artlett   IMMUNOLOGY LETTERS

Inflammation and fibrosis

(2018) Matthias Mack   MATRIX BIOLOGY

Enriched environment improves behavioral performance and attenuates inflammatory response induced by TNF-α in healthy adult mice

(2017) Shehong Zhang et al.   European Journal of Inflammation

The effect of adiponectin on LPS-induced inflammation via autophagy in RAW 264.7 macrophages

(2017) Xiaoliang Wang et al.   European Journal of Inflammation

Conditioned medium from human gingival mesenchymal stem cells protects motor-neuron-like NSC-34 cells against scratch-injury-induced cell death

(2017) Thangavelu Soundara Rajan et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Innate immunity may play a role in growth and relapse of chordoid meningioma

(2017) Ivan Presta et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Tolerability and benefit of a tetramethoxyluteolin-containing skin lotion

(2017) Theoharis C Theoharides et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

The pathophysiology of anaphylaxis

(2017) Laurent L. Reber et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Ethanol-mediated suppression of IL-37 licenses alcoholic liver disease

(2017) Felix Grabherr et al.   LIVER INTERNATIONAL

IL-33-ST2 Axis in Liver Disease: Progression and Challenge

(2017) Zijian Sun et al.   MEDIATORS OF INFLAMMATION

IL-37 Suppresses MyD88-mediated Inflammatory Responses in Human Aortic Valve Interstitial Cells

(2017) Qiong Zhan et al.   MOLECULAR MEDICINE

Mast cell and eosinophil surface receptors as targets for anti-allergic therapy

(2017) Roopesh Singh Gangwar et al.   PHARMACOLOGY & THERAPEUTICS

SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors

(2017) Alexandra Taracanova et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Identification of Biomarkers for Tubular Injury and Interstitial Fibrosis in Chronic Kidney Disease

(2017) Shunsaku Nakagawa   YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN

IL-37 a New IL-1 Family Member Emerges as a Key Suppressor of Asthma Mediated by Mast Cells

(2016) P. Conti et al.   IMMUNOLOGICAL INVESTIGATIONS

Levels of circulating soluble receptor activator of NF-κB and interleukins-1 predicting outcome of locally advanced basal cell carcinoma

(2016) Quan Lin et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

The Alarmin IL-33 Derived from HSV-2-Infected Keratinocytes Triggers Mast Cell-Mediated Antiviral Innate Immunity

(2016) Rui Aoki et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

IgE and mast cells in host defense against parasites and venoms

(2016) Kaori Mukai et al.   Seminars in Immunopathology

The IL-1 cytokine family and its role in inflammation and fibrosis in the lung

(2016) L. A. Borthwick   Seminars in Immunopathology

IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis

(2016) Rossana G. Iannitti et al.   Nature Communications

Inflammasome-Independent Regulation of IL-1-Family Cytokines

(2015) Mihai G. Netea et al.   Annual Review of Immunology

Mast Cells, Mastocytosis, and Related Disorders

(2015) Theoharis C. Theoharides et al.   NEW ENGLAND JOURNAL OF MEDICINE

IL-37 Expression is Upregulated in Patients with Tuberculosis and Induces Macrophages Towards an M2-like Phenotype

(2015) Z. Huang et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

The inflammatory response in myocardial injury, repair and remodelling

(2014) Nikolaos G. Frangogiannis   Nature Reviews Cardiology

Suppression of antigen-specific adaptive immunity by IL-37 via induction of tolerogenic dendritic cells

(2014) Yuchun Luo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Fibulin-2 deficiency attenuates angiotensin II-induced cardiac hypertrophy by reducing transforming growth factor-β signalling

(2013) Hangxiang Zhang et al.   CLINICAL SCIENCE

The Interleukin-1 Family: Back to the Future

(2013) Cecilia Garlanda et al.   IMMUNITY

Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis

(2013) Georg Lorenz et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Interleukin-37

(2013) Charles A. Dinarello et al.   SEMINARS IN IMMUNOLOGY

Do mast cells link obesity and asthma?

(2012) N. Sismanopoulos et al.   ALLERGY

Toll-Like Receptor 2–Mediated Intestinal Injury and Enteric Tumor Necrosis Factor Receptor I Contribute to Liver Fibrosis in Mice

(2012) Phillipp Hartmann et al.   GASTROENTEROLOGY

Update on Keloid Management: Clinical and Basic Science Advances

(2012) Martha H. Viera et al.   Advances in Wound Care

Cytokine/anti-cytokine therapy - novel treatments for asthma?

(2011) Philip M Hansbro et al.   BRITISH JOURNAL OF PHARMACOLOGY

Fibrosis and immune dysregulation in systemic sclerosis

(2010) Carlo Chizzolini et al.   AUTOIMMUNITY REVIEWS

Immunological aspect of cardiac remodeling: T lymphocyte subsets in inflammation-mediated cardiac fibrosis

(2010) Liu Wei   EXPERIMENTAL AND MOLECULAR PATHOLOGY

IL-37 is a fundamental inhibitor of innate immunity

(2010) Marcel F Nold et al.   NATURE IMMUNOLOGY

Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy

(2010) Carolyn Y. Ho et al.   NEW ENGLAND JOURNAL OF MEDICINE

IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin

(2010) T. C. Theoharides et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA